CDC48 antibodies are immunoreagents designed to detect and characterize the Cdc48 protein (also known as p97 or VCP in mammals). These antibodies enable researchers to study:
CDC48 antibodies have been instrumental in demonstrating Cdc48’s role in ubiquitin homeostasis. For example:
Ubiquitin recycling: Cdc48 deficiency increases polyubiquitinated proteins and depletes free ubiquitin pools, as shown by immunoprecipitation and Western blotting using anti-ubiquitin and anti-Cdc48 antibodies .
Aggregate resolution: Antibody-based assays revealed that Cdc48 collaborates with cofactors Ufd1/Npl4 to disassemble ubiquitinated aggregates, facilitating proteasomal degradation .
Cln3 cyclin stability: In cdc48-3 mutants, anti-HA and anti-FLAG antibodies detected reduced nuclear Cln3 levels and accelerated degradation, linking Cdc48 to G1/S transition .
Mammalian cyclin D1: shRNA-mediated Cdc48 knockdown in 3T3 cells, analyzed via anti-Ccnd1 antibodies, showed decreased nuclear cyclin D1 and delayed cell cycle entry .
ERAD and UPS: Cdc48 antibodies confirmed its interaction with Ufd1/Npl4 to retrotranslocate misfolded ER proteins for proteasomal degradation .
Metabolic dysregulation: Metabolomics in cdc48-3 yeast strains (using anti-Cdc48 antibodies) revealed glycolytic pathway disruptions .
Phosphorylation-dependent regulation: Anti-FLAG antibodies identified Cdc48’s phosphorylation by CDKs, which stabilizes G1 cyclins .
Cross-reactivity: Some antibodies (e.g., anti-Ubx2-7) show nonspecific binding in stress conditions .
Epitope masking: Cdc48’s ATPase activity induces conformational changes, requiring optimized solubilization for IP .
KEGG: sce:YDL126C
STRING: 4932.YDL126C